#Glenmark Pharmaceuticals on Tuesday announced its interim data of 503 patients from its ... - Latest Tweet by IANS Tweets
The latest Tweet by IANS Tweets states, '#Glenmark Pharmaceuticals on Tuesday announced its interim data of 503 patients from its Post Marketing Surveillance (PMS) study on #Favipiravir in India. Photo: IANS (File)'
(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter, Instagram and Youtube. The above post is embeded directly from the user's social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)